| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $0 | -100.0% |
| R&D Expense | $32.8M | +4.1% |
| SG&A Expense | $4.7M | -26.1% |
| Operating Income | -$37.5M | -8.8% |
| Pre-tax Income | -$24.3M | +27.6% |
| Income Tax | $244K | +135.5% |
| Net Income | -$24.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $200.0M | +27.2% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $201.7M | -8.2% |
| Total Assets | $226.6M | -7.9% |
| Current Liabilities | $6.1M | +50.0% |
| Total Liabilities | $7.8M | +36.3% |
| Stockholders' Equity | $218.8M | -9.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.7M | -26.3% |
| Capital Expenditures | $362K | -38.1% |
| Investing Cash Flow | $61.5M | +196.3% |
| Financing Cash Flow | -$9K | — |
| Free Cash Flow | -$19.1M | -23.9% |
| +25.4% |
| EPS (Basic) | -$0.81 | +25.0% |
| EPS (Diluted) | -$0.81 | +25.0% |